Sign Up Today and Learn More About GPN Vaccines Stock
Invest in or calculate the value of your shares in GPN Vaccines or other pre-IPO companies through EquityZen's platform.

GPN Vaccines Stock (GPVA)
GPN Vaccines is a vaccine that is used to prevent the spread of streptococcus pneumoniae.
About GPN Vaccines Stock
Founded
2017
Industries
Software, Artificial Intelligence, Data and Analytics
GPN Vaccines Press Mentions
Stay in the know about the latest news on GPN Vaccines
Modified streptococcal immunogen and uses thereof
patents • Apr 02, 2025
Dose Escalation Approved and Dosing Commenced in Second Cohort of GPN Vaccines’ Phase 1 Clinical Trial in Older Adults
einpresswire • Nov 12, 2024
GPN Vaccines Welcomes Dr. Bruce Forrest as Chief Scientific Officer
einpresswire • Oct 17, 2024
The Australian Financial Review on LinkedIn: Aussie vaccine start-up scores $300m valuation
linkedin • Jun 26, 2024
Aussie start-up GPN Vaccines scores $300m valuation from funding round led by Forepont Capital, Kern Capital
afr • Jun 26, 2024
GPN Vaccines Management
Leadership team at GPN Vaccines
Chief Executive Officer & Chairman
Tim Hirst
Chief Operating Officer
Lauren Giorgio

Join now and verify your accreditation status to gain access to:
- GPN Vaccines Current Valuation
- GPN Vaccines Stock Price
- GPN Vaccines Management
- Available deals in GPN Vaccines and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- GPN Vaccines Cap Table and Funding History by Share Class and Liquidity Preferences
- GPN Vaccines Revenue and Financials
- GPN Vaccines Highlights
- GPN Vaccines Business Model
- GPN Vaccines Risk Factors
- GPN Vaccines Research Report from SACRA Research
Trading GPN Vaccines Stock
How to invest in GPN Vaccines stock?
Accredited investors can buy pre-IPO stock in companies like GPN Vaccines through EquityZen funds. These investments are made available by existing GPN Vaccines shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell GPN Vaccines stock?
Shareholders can sell their GPN Vaccines stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."